COAGULATION DISORDER
Clinical trials for COAGULATION DISORDER explained in plain language.
Never miss a new study
Get alerted when new COAGULATION DISORDER trials appear
Sign up with your email to follow new studies for COAGULATION DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to reverse blood thinners quickly for urgent surgery
Disease control Recruiting nowThis study tests a new drug called TAK-330 against the usual treatment to reverse the effects of blood thinners (Factor Xa inhibitors) in people who need urgent surgery. About 440 adults will be randomly assigned to receive either TAK-330 or standard care before their procedure. …
Matched conditions: COAGULATION DISORDER
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New trial aims to stop deadly bleeding after birth
Disease control Recruiting nowThis study tests whether giving a clotting protein called factor XIII early can reduce blood loss in women with heavy bleeding after childbirth. About 988 women having a vaginal delivery will be randomly assigned to receive either factor XIII plus standard care or standard care a…
Matched conditions: COAGULATION DISORDER
Phase: PHASE4 • Sponsor: Christian Haslinger • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC
-
Massive study aims to crack the code on Kids' medications
Knowledge-focused Recruiting nowThis study is collecting blood and other samples from 5,000 children and young adults (under 21) who are already taking certain medications as part of their regular care. The goal is to understand how these drugs move through and affect children's bodies, so doctors can prescribe…
Matched conditions: COAGULATION DISORDER
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:00 UTC